Evaxion Biotech AS (EVAX)
3.95
-0.03
(-0.75%)
USD |
NASDAQ |
May 03, 16:00
3.95
0.00 (0.00%)
After-Hours: 18:04
Evaxion Biotech Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2022 | -0.744M |
| March 31, 2022 | -1.162M |
| December 31, 2021 | -1.33M |
| September 30, 2021 | -1.415M |
| Date | Value |
|---|---|
| June 30, 2021 | -1.089M |
| March 31, 2021 | -0.639M |
| December 31, 2020 | -0.393M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.415M
Minimum
Sep 2021
-0.393M
Maximum
Dec 2020
-0.9674M
Average
-1.089M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
| Ascendis Pharma A/S | 310.14M |
| DBV Technologies SA | -0.808M |
| Cellectis SA | -15.51M |
| Adaptimmune Therapeutics PLC | 176.54M |
| Akari Therapeutics PLC | -- |